Increased serum sLOX-1 have also been associated with arterial stiffness [38], coronary in-stent restenosis in patients with stable CAD [39], as well as with an increased risk of periprocedural myocardial infarction in stable CAD patients undergoing elective percutaneous coronary intervention [40]. Here, OLR1 is linked to coronary artery disorder.